Thomas Meyer 13D/13G Filings for Altamira Therapeutics Ltd. (CYTO)

Thomas Meyer 13D and 13G filings for Altamira Therapeutics Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-09-13
08:00 am
Purchase
2022-09-0913DALTAMIRA THERAPEUTICS LTD SHS
CYTO
Thomas Meyer4,193
8.000%
1,284increase
(+44.14%)
Filing
2022-05-13
08:32 am
Purchase
2022-05-1213DALTAMIRA THERAPEUTICS LTD SHS
CYTO
Thomas Meyer2,909
7.400%
866increase
(+42.39%)
Filing